MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Open Forum Infectious Diseases
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,365 results · 1 filter active ·
Results by year
20112025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,365 works in the cohort · of 4,299,418page 8 of 28

Labels cover 2 of 1,365 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,365 of 1,365 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
639. Time to Recurrence of <i>Clostridioides difficile</i> Infection (rCDI) is Rapid Following Completion of Standard of Care Antibiotics: Results from ECOSPOR-III, a Phase 3 Double-Blind, Placebo-Controlled Randomized Trial of SER-109, an Investigational Microbiome Therapeutic
Thomas Louie, Matthew Sims, Richard Nathan, Steven O’Marro, Princy Kumar, Elaine E Wang +4 more
2021· article· en· Open Forum Infectious Diseases· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
3
citations
fundno affunlabeled
COVID-19 Convalescent Plasma Therapy: Long-term Implications
Hyunah Yoon, Yi Li, Keith Goldfeld, Gia Cobb, Caroline L Sturm-Reganato, Dushyantha Jayaweera +60 more
2023· article· en· Open Forum Infectious Diseases· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
3
citations
affunlabeled
Association of Daily Body Temperature, White Blood Cell Count, and C-reactive Protein With Mortality and Persistent Bacteremia in Patients With <i>Staphylococcus Aureus</i> Bacteremia: A Post Hoc Analysis of the CAMERA2 Randomized Clinical Trial
Sean Wei Xiang Ong, Nick Daneman, Joshua S. Davis, Steven Y. C. Tong, David Chien Lye, Dafna Yahav +37 more
2025· article· en· Open Forum Infectious Diseases· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
3
citations
← previousnext →

How this was built: Screen · Findings · About